Q2 2021 Arbutus Biopharma Corp Earnings Call Transcript

Aug 05, 2021 / 12:45PM GMT
Operator

Good day, and thank you for standing by. Welcome to the Arbutus Biopharma Corporation 2021 Second Quarter Financial Results and Corporate Update Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions) I would now like to hand the conference over to your speaker today, Ms. Pam Murphy. Please go ahead.

Pam Murphy - Arbutus Biopharma Corporation - IR Consultant

Good morning, everyone. On the call from the Arbutus executive team are Bill Collier, President and Chief Executive Officer; Dave Hastings, Chief Financial Officer; Dr. Gaston Picchio, Chief Development Officer; and Dr. Mike Sofia, Chief Scientific Officer. Bill will begin with a review of the second quarter and first half accomplishments, clinical development and remaining 2021 corporate objectives, followed by Dave Hastings who will provide a review of the company's second quarter financial results.

We'll then open up the call for Q&A, and Mike and Gaston will be available to address research and clinical development-related

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot